Zora Biosciences commercializes VTT's biotechnology expertise
VTT Technical Research Center of Finland has spun-off Zora Biosciences Oy, the only company in the Nordic countries to offer metabolomics services to drug developers. Zora also develops biomarkers, which, for example, make it possible to detect early signs of cardiovascular disease.
VTT Technical Research Center of Finland has launched a spin-off company, Zora Biosciences Oy. "Zora's speciality field of metabolomics is a major driver of biomedical and pharmaceutical research", says Matej Orešic, founder and chairman of the board.
Zora's business model is two-fold. Zora will provide sophisticated laboratory services to pharmaceutical industry in the area of metabolomics and associated bioinformatics. Also, based on this advanced laboratory expertise Zora will develop prognostic and diagnostic biomarkers for human diseases as well as drug safety and efficacy monitoring.
Zora will aggressively expand its biomarker portfolio for licensing the discoveries to laboratory assay providers. At present, Zora's biomarker portfolio includes a promising discovery for screening patients susceptible to side effects of statins, which are powerful cholesterol lowering drugs. Statin medication is used by millions world-wide as part of their treatment regimen for cardiovascular diseases. Zora is also developing prognostic and diagnostics tools for improved healthcare management of diabetes and coronary artery disease among other indication areas.
Zora is funded by VTT, Slovenian private investor Gomar D.D., and Seedcap II Ky, managed by Innofinance Oy. "Zora has strong potential for rapid business growth and internationalization, which has attracted a committed investor base for the company", says Reini Hurme, Zora CEO. Globally there is only a handful of companies specializing in metabolomics, in the Nordic countries Zora is the only one.
Zora Biosciences Oy
Zora Biosciences offers advanced laboratory services for the needs of the pharmaceutical industry in the fields of metabolomics and bioinformatics. Based on this advanced laboratory competence, Zora also develops prognostic and diagnostic biomarkers for disease diagnosis and monitoring of the efficacy and safety of drugs.
Press Office | alfa
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
An international team of scientists has proposed a new multi-disciplinary approach in which an array of new technologies will allow us to map biodiversity and the risks that wildlife is facing at the scale of whole landscapes. The findings are published in Nature Ecology and Evolution. This international research is led by the Kunming Institute of Zoology from China, University of East Anglia, University of Leicester and the Leibniz Institute for Zoo and Wildlife Research.
Using a combination of satellite and ground data, the team proposes that it is now possible to map biodiversity with an accuracy that has not been previously...
Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.
Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...
Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.
As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...
Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.
With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...
Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine
Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...